Nurse Practitioner, Family · Akron, OH
NPI
1801305859
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1260 Independence Ave
Akron, OH, 44310
Phone (234) 312-2111
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
367 services
Medicare patients, 2024
85
Average age 71
Drug cost, 2024
$2.1M
4,012 prescriptions
Company payments, 2025
$1,207
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by McKenzie Baker was code 99214 (office e&m - established), 68 times for 53 patients. In total McKenzie Baker billed 367 services in 17 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 68 | 53 | $77.44 | $5,266 |
| 83036 Blood Count | Office | 61 | 49 | $9.52 | $581 |
| 95251 Test - Miscellaneous | Office | 48 | 34 | $21.97 | $1,055 |
| G0108 Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 37 | 19 | $39.71 | $1,469 |
| 82962 Clinical Chemistry | Office | 28 | 26 | $3.21 | $89.88 |
| 99205 Office E&M - New | Office | 19 | 19 | $106.99 | $2,033 |
| 99215 Office E&M - Established | Office | 19 | 19 | $110.22 | $2,094 |
| 99204 Office E&M - New | Office | 12 | 12 | $82.84 | $994 |
By year: 2022 $20K for 345 services; 2023 $15K for 244 services; 2024 $16K for 367 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 61 | 49 | $9.52 | $581 |
| 82962 Clinical Chemistry | 28 | 26 | $3.21 | $89.88 |
Medicare prescription drug claims, 2024
In 2024, the drug McKenzie Baker prescribed most often to Medicare patients was Ozempic (Semaglutide), with 358 prescriptions and refills. In total McKenzie Baker wrote 4,012 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 358 | 514 | 113 | $485K |
| Levothyroxine Sodium Generic | 265 | 553 | 91 | $2,903 |
| Metformin Hcl Generic | 198 | 414 | 73 | $1,565 |
| Trulicity Dulaglutide | 194 | 285 | 79 | $273K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 165 | 381 | 92 | $22K |
| Metformin Hcl Er Metformin Hcl | 161 | 395 | 71 | $3,621 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 144 | 345 | 74 | $17K |
| Mounjaro Tirzepatide | 142 | 188 | 52 | $198K |
| Jardiance Empagliflozin | 105 | 263 | 50 | $152K |
| Atorvastatin Calcium Generic | 102 | 235 | 45 | $670 |
| Alcohol Prep Pads Alcohol Antiseptic Pads | 97 | 189 | 52 | $2,264 |
| Farxiga Dapagliflozin Propanediol | 95 | 201 | 42 | $111K |
| Gvoke Hypopen 2-Pack Glucagon | 90 | 92 | 66 | $63K |
| Humalog Kwikpen U-100 Insulin Lispro | 83 | 208 | 40 | $33K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 71 | 131 | 37 | $15K |
Brand drugs: 2,170 claims; generic drugs: 1,182 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid McKenzie Baker $1,207 ($1,207 in general payments such as food, travel and fees) from 15 companies. The largest payer was Medtronic, Inc. with $545.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 5 | $545 |
| Sequel Med Tech, LLC | 2 | $159 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $134 |
| Novo Nordisk Inc NVO | 4 | $76.3 |
| Insulet Corporation PODD | 2 | $47.78 |
| Beta Bionics, Inc. BBNX | 2 | $43.42 |
| Ascensia Diabetes Care Us Inc. | 2 | $34.9 |
| Dexcom, Inc. DXCM | 1 | $31.13 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $27.84 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $24.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.